-
CTN Primary Care SIG Webinar: Engaging Rural Communities and Practices in Substance Use Research (Jan. 27, 12pm ET)
The NIH recently launched a $30 million Communities Advancing Research Equity (CARE) for Health Initiative, which funds primary care research network hubs to engage rural communities and practices in research. As part of the pilot, CTN-0139 (Co-Care) is engaging with two newly funded rural hubs to expand engagement and recruitment in small rural practices. The January 27, 2025 Primary Care SIG meeting (12pm ET, 9am PT) will feature a panel to discuss how CARE for Health synergistically can enhance and contribute to CTN trials. The panel will include: Connect to the Zoom meeting.ID: 996 0835 1363Passcode: 291918 Questions? Contact Maria Prado at pradom@uw.edu.
-
Youth SIG Webinar Recording Available: Scaling Out Evidence-Based Interventions Through Primary Care Settings: A Case Study of the PAAS Program
The CTN Youth SIG hosted the following webinar in November 2024. The recording is now available! Title: Scaling Out Evidence-Based Interventions Through Primary Care Settings: A Case Study of the Pathways for African Americans (PAAS) Program Presenter:Velma McBride Murry, PhDLois Autrey Betts Endowed ChairCo-Director, Vanderbilt University Medical Center Program for Health Equity ResearchDistinguished University Professor, Departments of Health Policy & Human and Organizational Development, Vanderbilt University This presentation highlighted the role of primary care setting as a conduit for evidence-based intervention access for families. In addition, attention was given the need to focus on system level interventions to reduce the need for families and youth to be “resilient.” Dr. Velma McBride Murry holds the Lois Autrey Betts Endowed Chair, previously held an appointed position of Associate Provost, Research and Innovation, currently serves as Co-Director of the Vanderbilt University Medical Center Program for Health Equity Research (PHER), and is a University Distinguished Professor in Departments of Health Policy [Vanderbilt School of Medicine] and Human and Organizational Development [Peabody College]. She is Past President of the Society for Research on Adolescence and current President of The International Consortium of Developmental Science Societies. McBride Murry is one of the 100 elected members to the 2020 Class of the National Academic of Medicine. She is an appointed standing member of National Institutes of Health National Advisory Mental Health Research Council. Her research examines the significance of context to everyday life experiences of African American families and youth, focusing on processes through which racism, and other social structural stressors, cascade through families to…
-
Northeast Node Webinar: Medications for OUD for Youth (Dec. 5, 12pm ET)
In 2021, one in every 100 kids aged 12-17 had an opioid use disorder (OUD). Medication treatment for OUD (MOUD) is effective, but only 3-4% of youth who need it receive treatment. This session will outline features of youth treatment for OUD, evidence for treating youth with medications, youth MOUD uptake and retention, the role of families in care, and opportunities for interdisciplinary care teams in outpatient settings. In this extended session, Dr. Marc Fishman (Mountain Manor & Johns Hopkins) will also facilitate interactive case reviews with attendees. If you have a case you would like to present, please let Bethany McLeman know: bethany.m.mcleman@dartmouth.edu Register for the webinar here!
-
CTN T&I SIG Webinar: Implementation Outcomes in NIDA Clinical Trials Network Studies (Nov. 19, 9am PT)
Join the Translation and Implementation SIG on November 19th (9am-10am PT) for their next session, titled, “Implementation Outcomes in NIDA Clinical Trials Network Studies: A Systematic Review of Studies Conducted Over 25 Years in the CTN.“ This webinar will be presented by Sophia Gonzalez, MPH and Joe Glass, PhD, MSW of the CTN T&I Implementation Outcomes Workgroup and will focus on a study to explore and document the evolution of the inclusion of implementation outcomes across trials conducted within the CTN, characterize outcomes included, identify gaps and potential opportunities to strengthen implementation research within the CTN, and inform the broader field of SUD treatment. Contact Helene Chokron Garneau at hchokgar@stanford.edu if you would like to attend!
-
CTN Youth SIG Webinar: Falling Through the Cracks: The Struggle of Adolescents with OUD (Sept 20, 11am ET)
The CTN Youth SIG is pleased to invite you to an upcoming presentation/webinar: Falling Through the Cracks: The Struggle of Adolescents with Opioid Use Disorder in the Face of Limited Treatment Options Friday, September 20th, 2024 (11:00 a.m.–12:00 p.m. ET) Presenter: Sivabalaji Kaliamurthy MDAssistant Professor of Psychiatry, Howard UniversityDirector, Addiction Program at Children’s National, Washington, DC Dr. Kaliamurthy, a physician specialized in pediatric addictions, is board-certified in general psychiatry, child and adolescent psychiatry, addiction psychiatry and addiction medicine. He was pivotal in establishing the Addiction Clinic at Children’s National to treat children with psychiatric and substance use disorders. Dr. Kaliamurthy’s current research centers on evaluating the clinical outcomes associated with the use of medications for opioid use disorder in adolescents. In this presentation, Dr. Kaliamurthy will examine a case involving an adolescent who sought treatment within a pediatric health care system for fentanyl use. The focus will be on the challenges identified in delivering care to adolescents with opioid use disorder. He will also highlight barriers to treatment that must be overcome to deliver the minimum necessary care to ensure engagement in medication treatment for opioid use disorder and reducing overdose risk. Register for the Zoom Webinar Upcoming Youth SIG Seminar Speakers in 2024: November 15 (11am-12pm ET) – Dr. Velma Murry
-
Early Bird Rates for AHSR 2024: LAST WEEK!
Only one week left to get AHSR 2024 early bird tickets! This year’s conference is hosted by the Center for Dissemination and Implementation, a Stanford University initiative and part of the CTN Western States Node. Pricing: Payment and Refunds: Full payment is required at the time of registration. Attendees will have until September 13, 2024 to modify/cancel registration. Canceling before the deadline will result in a full refund minus processing fees. Register for AHSR 2024 here!
-
CTN Annual Scientific Meeting: October 21-23, 2024 – Poster submissions open!
The National Drug Abuse Treatment Clinical Trials Network (CTN) will hold its Annual Scientific Meeting celebrating the 25th Anniversary of the CTN on Monday-Wednesday, October 21-23, 2024. The meeting will be held at the Crystal Gateway Marriott in Arlington, Virginia. Registration and hotel information coming soon — on or before the week of July 29. Poster session information Sharing of the results, experiences, techniques, and observations from performing our trials is a critical and exciting part of the CTN experience. To that end, CTN members are encouraged to submit posters for display at the 2024 CTN Annual Scientific Meeting Poster Session celebrating the 25th Anniversary of the CTN to be held on Monday, October 21, 2024. Poster submissions should be relatable to the CTN either directly (i.e. reporting on CTN studies, data, etc.) or indirectly (i.e. information that informs potential future CTN projects). As in previous years, we will consider new posters as well as posters that were presented at meetings over the past year. Event: CTN Annual Scientific Meeting Poster SessionVenue: Crystal Gateway Marriott (Arlington, VA)Date: Monday, October 21, 2024Time: 4:30 – 6:30 p.m. ET (exact times subject to change) Guidelines: In-person poster presenters will be provided with information on local poster printing options or shipping items directly to the hotel. Virtual Poster Display We will also post electronic copies of the posters on the meeting website. This will allow those not available for the in-person poster session to share their work. Please indicate on the submission form whether you are submitting the poster for…
-
Primary Care SIG Webinar: Are We There Yet? 25 Years of Research on Treating OUD in Primary Care (July 22, 12pm ET)
Join the CTN Primary Care SIG on July 22, 2024 (12-1pm EST) for their next webinar, featuring David Fiellin, MD from Yale School of Medicine presenting “Are we there yet? 25 years of research on treating OUD in primary care.” Please join the webinar here (no registration required).Passcode: 201068 Interested in presenting at a future Primary Care SIG meeting? Email Joe LeMaster at jlemaster@kumc.edu or Sebastian Tong at setong@uw.edu Posted July 15, 2024
-
CTN Youth SIG Webinar, July 19, 2024, 11am ET
The CTN Youth SIG is pleased to invite you to an upcoming presentation with two invited speakers: Presenters: Jesse D. Hinckley, MD, PhD and Chris Hammond, MH, PhD Friday, July 19th, 2024 (11:00 a.m.–12:00 p.m. ET) Join Zoom Meeting:https://dartmouth.zoom.us/j/94616304667?pwd=MHhGUjBzcmVNUVVlV1IyT0hjR3YrUT09 Meeting ID: 946 1630 4667Passcode: 047757One tap mobile+16469313860,,94616304667#,,,,*047757# US+13017158592,,94616304667#,,,,*047757# US (Washington DC) Exploring the association of cannabis use with depression and suicidal behavior in youth Jesse D. Hinckley, MD, PhDDivision of Addiction Science, Treatment & Prevention, Department of Psychiatry, University of Colorado School of Medicine School of Medicine The co-occurrence MDD and cannabis use is associated with worse mental health and substance use outcomes. Data will be presented from a secondary analysis of the National Comorbidity Survey-Adolescent Supplement (N=10,123), a nationally representative study of youth aged 13-18 years, exploring the association of cannabis use with major depressive disorder and suicidal behavior. Findings from this study will be considered in context of the extant literature to further explore the association between cannabis use and depression and potential mechanisms whereby these comorbid problems may increase the risk of youth engaging in suicidal behavior. Dr. Jesse Hinckley is an assistant clinical professor in the Division of Addiction Research, Treatment & Prevention within the Department of Psychiatry. Dr. Hinckley currently splits his time as a child and adolescent psychiatrist at a teaching hospital in Idaho and his research efforts at the University of Colorado School of Medicine. Dr. Hinckley’s primary research interests include better understanding the development of substance use disorders in adolescents, the interaction between substance use…
-
NIDA HIV Seminar Series: Social & Political Determinants of HIV Among People Who Use Drugs (July 31, 1pm ET)
Join Dr. Ricky Bluthenthal, PhD, on July 31, 2024 (1-2pm ET) for the next NIDA HIV Seminar! Dr. Bluthenthal is a Distinguished Professor of Population and Public Health Sciences at the Keck School of Medicine at the University of Southern California. He conducts community-partnered research at the intersection of harm reduction and health disparities among people who use drugs. In this session, Dr. Bluthenthal will talk about social and political determinants of HIV among people who use drugs. Register for the seminar here!